Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: CEO's ARE judged based on PPS and rightly so

Re: "RG has presided over a PPS decline from a high of 42 cents on his first day, to the current 10 cents"

True, but RG has no control over licenses sales and that has been the only source of EPS until he arrived. The new businesses he's aggressively moved into can't be expected to return any significant EPS for some time.

RG has been building the foundation for EPS growth. EPS drives PPS.

Share
New Message
Please login to post a reply